|
|
Upcoming Medical Policies BlueCross BlueShield of Tennessee |
Each medical policy listed below will become effective on the date indicated, and will be included in the Medical Policy Manual for BlueCross BlueShield of Tennessee on that effective date.
Medical policies are developed using an evidence-based evaluation process. The medical evidence used in this process comes from several sources, including independent medical technology review organizations, the peer reviewed medical literature, and opinions from appropriate network specialists. All Medical Policies are reviewed by a panel of internal and external physicians before being adopted by the company.
Topics due to be included in the Medical Policy Manual on 6/11/2013
Topics due to be included in the Medical Policy Manual on 7/13/2013
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Topics due to be included in the Medical Policy Manual on 6/11/2013:
Implantable Sinus Spacers and Stents
Interferential Current Stimulation
Interspinous Fixation (Fusion) Devices
Non-invasive Prenatal Testing Using Cell-free Fetal DNA (cffDNA)
Topics due to be included in the Medical Policy Manual on 6/12/2013:
Topics due to be included in the Medical Policy Manual on 7/13/2013:
Intravenous Immune Globulin (IVIG) Therapy
Radiofrequency Ablation for Treatment of Tumors
Last Review Date8 5/16/2013